Fellow provides peer-reviewed, mail-in semen analysis for clinics looking for improved compliance and a patient-friendly solution to fertility testing.
Fellow's CLIA-certified diagnostics lab combines the ease of a mail-in semen analysis with peer-reviewed clinical performance to provide clinically valid results§in less than 2 business days from when a specimen reaches our laboratory.
Get in touchWe dramatically improve the testing experience for patients and clinic staff members, achieving compliance rates of up to 97%‡ (compared to an established average of about 50% for in-office testing*) while providing results that are clinically validated to be as accurate as those from a fresh semen sample analyzed within 1 hour.
Success Stories
Fellow is building a biobank of semen samples so that the most potent and accessible analyte—seminal fluid— can be used to yield breakthroughs across medical disciplines.
In partnership with leading experts and universities, we pioneer research in male reproductive sciences. Read our abstracts and articles here.
Our science§ Samplaski et al. Development and validation of a novel mail-in semen analysis system and the correlation between one hour and delayed semen analysis testing; Fertil Steril. 2021;115(4):922-929
† Tolani et al. Mail-in semen analysis breaks down racial, educational, and income barriers to semen analysis completion. Proceedings from the Pacific Coast Reproductive Society (PCRS) Annual Meeting 2024. Indian Wells, CA.
‡ Gu et al. High compliance with Fellow semen analysis testing across the United States irrespective of clinical practice type. Proceedings from the American Urological Association Annual Meeting 2024. San Antonio, TX.
* Multiple publications report only 1 in 2 patients complete post-vasectomy semen analysis, including [1] Bradshaw et al., Urology, 2019, [2] Duplisea and Whelan, Journal of Urology, 2013 and [3] Johnson (Siegert) et al., Andrology & Gynecology: Current Research, 2019.